omniture
SYMAP信迈医疗

Latest News

Milestone: Renal Nerve Mapping / Selective Renal Denervation (msRDN) System by SyMap Medical Ltd Approved for Treatment of Uncontrolled Hypertension in China

SUZHOU, China, Aug. 12, 2024 /PRNewswire/ -- On August 6, 2024, the msRDN System (SyMapCath I®/ SYM...

2024-08-12 13:55 1368

TCT 2023: The Efficacy and Safety of the SMART Trial Presented by World Renowned Expert

SAN FRANCISCO, Nov. 10, 2023 /PRNewswire/ -- On October 26, 2023, SyMap Medical invited ProfessorFe...

2023-11-10 16:46 1467

EuroPCR 2023 | 6 Month Outcome of the SMART Study: satisfactory BP control achieved with reduced medication burden

PARIS, May 19, 2023 /PRNewswire/ -- On May 17th 2023, the six-month result of the SMART Study (Symp...

2023-05-19 14:54 1880

SyMap Targets Renal Denervation With a Unique Map-and-Ablate Technology

SUZHOU, China, March 16, 2022 /PRNewswire/ -- SyMap Medical is developing a selective map-and-ablat...

2022-03-16 21:00 1585

SyMap Medical Ltd Completed Enrollment in SMART Study for the Treatment of Uncontrolled Hypertension

SUZHOU, China, Feb. 23, 2022 /PRNewswire/ -- SyMap Medical Ltd. (Suzhou, China) announced successfu...

2022-02-23 21:00 2262

SyMap Medical Ltd. Announces its Strategic Collaboration with Pythagoras Medical

SUZHOU, China, Dec. 29, 2021 /PRNewswire/ -- SyMap Medical Ltd (SyMap) announced its strategic coll...

2021-12-29 20:30 2182

SyMap Medical Ltd. Closes Largest Financing Round in Renal Denervation Field

SUZHOU, China, Dec. 7, 2021 /PRNewswire/ -- SyMap Medical (SyMap) announced its latest financing ro...

2021-12-07 20:30 2255